A study of hurdles in mass treatment of schistosomiasis in KwaZulu-Natal, South Africa

  • A Randjelovic* University of Oslo
  • S G Frønæs* University of Oslo
  • M Munsami Department of Health
  • J D Kvalsvig University of KwaZulu-Natal
  • S G Zulu University of KwaZulu-Natal
  • S Gagai University of KwaZulu-Natal
  • A Maphumulo University of KwaZulu-Natal
  • L Sandvik Oslo University Hospital
  • S G Gundersen University of Agder
  • Eyrun Floerecke Kjetland
  • M Taylor University of KwaZulu-Natal
Keywords: health education, mass drug administration, mass-treatment, treatment, rural health, Praziquantel, schistosomiasis

Abstract

Background: It has been estimated that 700 million people worldwide and 5.2 million people in South Africa are in need of annual treatment for schistosomiasis. In accordance with the current policy the Department of Health (DoH) in KwaZulu-Natal province, South Africa, aimed to reach 75% treatment coverage in a mass treatment campaign (MTC) of schools in a schistosomiasis-endemic area. Methods: A cross-sectional study was designed to explore the implementation, coverage, challenges and limitations of a DoH MTC in a middle-income country. The study was conducted by exploring nurses’ and research team records, school enrolment lists and parental consent forms. Results: Slightly more than 10 000 learners in 43 primary and high schools were treated, achieving treatment coverage of 44.3%. A median of two schools per day were visited over the course of 39 days. We found that older learners, being male and attending a large school were independent significant predictors for low treatment coverage. Conclusion: Our results indicate a much lower coverage than recommended by the South African National Department of Health and World Health Organization (WHO). Coverage would likely increase through improved consent procedures and repeated schools visits. Further information is needed on how to increase compliance in older teenagers, males and learners in large schools. (Full text available online at www.medpharm.tandfonline.com/ojfp) S Afr Fam Pract 2015; DOI: 10.1080/20786190.2014.978121

Author Biographies

A Randjelovic*, University of Oslo
MD Faculty of Medicine University of Oslo Oslo Norway
S G Frønæs*, University of Oslo
MD Faculty of Medicine University of Oslo Oslo Norway
M Munsami, Department of Health
Department of Health Ugu District Port Shepstone South Africa
J D Kvalsvig, University of KwaZulu-Natal
PhD Discipline of Public Health Medicine Nelson R Mandela School of Medicine College of Health Sciences University of KwaZulu-Natal Durban
S G Zulu, University of KwaZulu-Natal
Discipline of Public Health Medicine Nelson R Mandela School of Medicine College of Health Sciences University of KwaZulu-Natal Durban
S Gagai, University of KwaZulu-Natal
Discipline of Public Health Medicine Nelson R Mandela School of Medicine College of Health Sciences University of KwaZulu-Natal Durban
A Maphumulo, University of KwaZulu-Natal
Discipline of Public Health Medicine Nelson R Mandela School of Medicine College of Health Sciences University of KwaZulu-Natal Durban
L Sandvik, Oslo University Hospital
PhD Department of Biostatistics Epidemiology and Health Economics Oslo University Hospital Oslo Norway
S G Gundersen, University of Agder
MD, PhD eResearch Department Sorlandet Hospital HF Institute for Development Studies University of Agder Kristiansand Norway
M Taylor, University of KwaZulu-Natal
PhD Discipline of Public Health Medicine Nelson R Mandela School of Medicine College of Health Sciences University of KwaZulu-Natal Durban
Published
2015-05-18
Section
Research Articles